Navigation Links
Metabolic Solutions Development Company Receives $1.1 Million NIH Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease
Date:10/6/2011

KALAMAZOO, Mich., Oct. 6, 2011 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today it has received a $1.1 million multi-year Small Business Technology Transfer Program (STTR) grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health (NIH). MSDC will use this new funding to further evaluate MSDC-0602 in animal models of fatty liver disease (FLD). FLD occurs worldwide and refers to a group of conditions which lead to an accumulation of excess fat in the liver of people who consume excessive alcohol or who are obese(1).

MSDC-0602 is a novel insulin sensitizer that is selective for a molecular target, mTOT, which functions as a "switch" connecting mitochondrial metabolism to important cell functions. In a recently completed Phase 2a study in patients diagnosed with type 2 diabetes, MSDC-0602 was shown to achieve significant glucose control and increase insulin sensitivity in a PPAR-independent manner.

"Our unique understanding of the mTOT biochemical pathway will enable MSDC's researchers, working in collaboration with our colleagues at the Washington University School of Medicine, to select compounds that treat the root cause of some of the most pressing health issues facing Americans today," said Stephen Benoit, chief executive officer, MSDC. "Importantly for patients diagnosed with fatty liver disease, these new therapeutics won't have the unwanted side effects associated with currently available insulin sensitizers."

Studies conducted under this grant will be led by principal investigators, Rolf Kletzien, PhD, senior vice president of research at MSDC, and Brian Finck, PhD, assistant professor in medicine, Washington University School of Medicine, Division of Geriatrics and Nutritional Science.

In previous preclinical studies funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the PPAR-independent pharmacology of MSD
'/>"/>

SOURCE Metabolic Solutions Development Company, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
4. NAFLD AND NASH Linked to Metabolic Syndrome and Cardiovascular Disease
5. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
6. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
7. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
8. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
9. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
10. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
11. Metabolic Solutions Development Company To Test Potential Treatment for Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Boston Scientific Corporation (NYSE: BSX ) is ... May 21-24 in Paris . ... and diversified set of data this year at EuroPCR," ... chief medical officer, Boston Scientific.  "The primary endpoint results ... PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... 2013  Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...
(Date:5/16/2013)... 2013 OrthoView PSL will allow ... access the widely-used OrthoView digital templating software via the ... to get started. OrthoView, the leading independent ... years, is dedicated to enabling orthopaedic surgeons in hospitals ... when printed film is unavailable. Over 5,000 orthopaedic surgeons ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... 12, 2011 Unilife Corporation ("Unilife" or the "Company") ... the development of its AutoInfusor™ portfolio of subcutaneous infusion ... 5mL, 7mL, and 10mL volumes. Unilife has ... of pharmaceutical and biotechnology companies with drugs that have ...
... one of the largest distributors of high-performance and engineering-grade ... new EVONIK VESTAKEEP® 5000 PEEK extruded stock shapes. ... most ductility of any PEEK material available in extruded ... Marketing at Modern Plastics. EVONIK VESTAKEEP® ...
Cached Medicine Technology:Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 2Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 3Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 4
(Date:5/18/2013)... of coffee is associated with a reduced risk ... disease, Mayo Clinic research shows. The findings were ... conference in Orlando, Fla. , PSC is ... results in inflammation and subsequent fibrosis that can ... and biliary cancer. , "While rare, PSC has ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Today, ... insurance agents’ role in Marketplaces . Zane ... traditional employer sponsored health benefits, is the leader ... and health reimbursement arrangements . , According ... and Human Services (HHS) recently released a much-anticipated ...
(Date:5/18/2013)... 18, 2013 The “World Healthcare IT ... studies the major market drivers, restraints, and opportunities in ... , Browse , 89 market ... TOC on "Healthcare IT Market" , ... on reports. , The global healthcare IT market is ...
(Date:5/18/2013)... As metal-on-metal hip implant ... Bernstein Liebhard LLP notes that a new study has ... damage before they experience any pain from a hip. ... will appear in the Journal of Bone & Joint ... of their hips. The researchers found tissue damage ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The “Sleep ... Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, ... Forecast to 2017” analyzes and studies the major market ... and Rest of the World. , Browse , ... 16 Figures , 318 ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... A new US research has found that young women are ... young men.The study, which contradicts the stereotype that men// are ... The Annals of Internal Medicine this week. ,Researchers from ... years after they were discharged from hospital after a heart ...
... new treatment for people with severe cases of multiple sclerosis, ... stem cells// from the patients’ blood, killing the cells that ... the healthy cells back to the body. The hope is ... system cells and the disease process can be stopped. ...
... humans and animals, the nerve cells must communicate with the ... a new study, biologists from Utah showed how a single ... to send these chemical signals. , The experimented ... the Scientists crippled the protein UNC-13. , " All ...
... technique for prostate cancers has been found out by researchers.// ... traditional exam for prostate cancer, the doctor takes six tissue ... University, researchers said that it is better to take more ... extended sector biopsy. They took 12 samples - ...
... The research involves a drug called zoledronic acid, which is ... in which calcium seeps from the bones. The drug was ... bone density, and the effect persisted for at least a ... the blood.// ,It will be about five years before ...
... drug Clarinex is coming on the market with an ... allergy drugs. "Billions of seasonal allergies, one tiny blue ... makes Claritin, the nation's best-selling prescription allergy drug. In ... switch Claritin to over-the-counter drug. A month's supply, which ...
Cached Medicine News:
... Our original design and available ... It does not have the wings ... much easier to remove. This is ... an inexpensive method to print a ...
... Volks drive to provide ... to bring you a lens ... in a non-contact slit lamp ... true 3D viewing of the ...
... writes and prints "Smart" labels. As well ... barcode on the label surface. SATO's industrial ... range of applications, including: Compliance Labeling, Warehouse ... Retail Labeling, Product Authentication. CL408e RFID and ...
... Gallery is a unique label design ... on an easy-to-use and intuitive user ... Label Gallery offers a family of ... multi-lingual user interface and complete barcode ...
Medicine Products: